First-in-human Study of 7MW4911 in GI Cancer
Clinical trial NCT07216560 · RECRUITING
Trial details
- NCT number
- NCT07216560
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-13
- Primary completion
- 2027-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.